GRI
GRI Bio, Inc.Company with tickers: GRI
CIK
1824293
CUSIP
3622AW502
Shares Outstanding
1,770,838
13F Activity (30d)
5 filings
5 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $2,003,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Research & Development | $361,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-2,003,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-1,998,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-1.61 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-1.61 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |